Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 20, 2026

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid
05:05

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid

Published on: June 17, 2025

How to validate outcome instruments for pemphigus.

Sylvie Bastuji-Garin1, Emilie Sbidian

  • 1Université Paris 12 (LIC EA4393), Creteil, France. sylvie.bastuji-garin@hmn.ap-hop-paris.fr

The Journal of Investigative Dermatology
|September 15, 2009
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epidermal necrolysis sequelae: A cohort study on prevalence and risk factors.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Management and predictors of ICU admission in DRESS: A multicentre retrospective cohort study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Topical treatments for chronic plaque psoriasis.

The Cochrane database of systematic reviews·2026
Same author

Comparative effectiveness of first-line anti-PD-1 versus cetuximab in advanced cutaneous squamous cell carcinoma: A nationwide population-based study using the French national health data system.

European journal of cancer (Oxford, England : 1990)·2026
Same author

Infection risk among psoriasis biologic-new users: A cohort study on the French National Health Data System.

Journal of the American Academy of Dermatology·2026
Same author

French guidelines on systemic treatments for moderate-to-severe psoriasis in adults: Update 2025.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same journal

Reducing plastic waste in skin-model research: Sustainable packaging as a practical first step.

The Journal of investigative dermatology·2026
Same journal

Modern serum proteomics in precision medicine: Toward disease stratification and predictive, proactive treatment strategies.

The Journal of investigative dermatology·2026
Same journal

An Integrated Skin Cell Atlas Decodes the Pilosebaceous Unit.

The Journal of investigative dermatology·2026
Same journal

Residual CSB activity explains mild UV-sensitive syndrome phenotype caused by CSB mutations.

The Journal of investigative dermatology·2026
Same journal

Charting a new melanoma risk factor: Satellite Naevus Prevalence in High-Risk and Population-Based Cohorts.

The Journal of investigative dermatology·2026
Same journal

Human keratinocytes and fibroblasts coordinate early cutaneous innate defenses against Candida auris.

The Journal of investigative dermatology·2026
See all related articles

This study critically evaluates outcome instruments for pemphigus, highlighting limitations in their validation. Methodological concerns regarding sample size and missing validation steps are discussed for reliable therapeutic trial tools.

Area of Science:

  • Dermatology
  • Clinical Trials
  • Biostatistics

Background:

  • Reliable outcome instruments are crucial for evaluating pemphigus treatments.
  • Existing instruments require rigorous validation for therapeutic trial use.

Purpose of the Study:

  • To critically assess the methodological rigor of outcome instrument validation for pemphigus.
  • To identify limitations in the assessment of reliability and validity for pemphigus outcome measures.

Main Methods:

  • Review of methodological aspects of instrument assessment.
  • Analysis of validation steps, including sensitivity to change and construct validity.

Main Results:

  • The validation of the assessed outcome instrument was based on a small sample size (15 patients).

More Related Videos

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

Measuring Psoriasis Severity at Home
02:28

Measuring Psoriasis Severity at Home

Published on: March 1, 2024

Related Experiment Videos

Last Updated: Jun 20, 2026

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid
05:05

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid

Published on: June 17, 2025

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

Measuring Psoriasis Severity at Home
02:28

Measuring Psoriasis Severity at Home

Published on: March 1, 2024

  • Key validation steps, such as sensitivity to change and construct validity, were not reported by the original authors.

    • Conclusions:

    • Methodological limitations in the current assessment of pemphigus outcome instruments necessitate further rigorous evaluation.
    • Improved validation methodologies are required to ensure the reliability and validity of tools used in pemphigus clinical trials.